Aarti Drugs Limited Receives Closure Directive for Amines Manufacturing Unit from GPCB
Aarti Drugs Limited has received a closure direction from the Gujarat Pollution Control Board (GPCB) regarding its manufacturing operations of Amines at a plant located in Bharuch, Gujarat. The directive mandates the closure of these specific operations due to non-compliances identified during an inspection by the GPCB.The company received the Closure Directions letter on July 18, 2026. This directive, issued under Section 33A of the Water (Prevention and Control of Pollution) Act, 1974, mandates the closure of the Amines manufacturing operations at the plant situated in Plot No. DP-94 to DP-96, Saykha Industrial Estate, Dist. Bharuch, Gujarat. The operational closure is set to be effective 15 days from the date of the issuance of the letter, alongside other related directions.
The action stems from an inspection conducted by GPCB on June 20, 2026, where certain non-compliances concerning the Water Act and Consolidated Consents and Authorization (CCA) conditions were observed at the manufacturing site.
Details of Closure Directive
Key details regarding the compliance directive received by Aarti Drugs Limited are as follows:| Authority | Nature of Action / Order | Date of Receipt |
|---|---|---|
| Gujarat Pollution Control Board (GPCB) | Closure Direction for Amines manufacturing operations | July 18, 2026 |
| Location Affected | Plot No. DP-94 to DP-96, Saykha Industrial Estate, Dist. Bharuch, Gujarat |
Operational Impact and Corrective Measures
Regarding the operational status, Aarti Drugs Limited stated that as the closure will be effective from the 15th day of the issuance, there is no immediate impact on the company's financial or operational activities as of the date. The company confirmed that all other manufacturing units remain fully operational.The company is actively addressing the observations made by the GPCB and is in the process of submitting a requisite response to secure the revocation of the closure directions. Aarti Drugs Limited has indicated that it will update stock exchanges regarding any material developments concerning this matter in the future.
AARTIDRUGS Stock Price Movement
Aarti Drugs Limited shed 0.21% of its value on Friday, with the stock settling at ₹419 amid intraday trading pressure. The shares traded a total volume of 221,704 during the session, having tested a high of ₹426.45 and finding support at ₹410.2.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.